Review
Open access
Aug 2026
Hypoxia fuels JAK/STAT-LIV1 signaling: A promising therapeutic avenue in triple-negative breast cancer.
The Hypoxia-STAT3-LIV-1-zinc signaling axis is proposed as a central regulatory node driving TNBC progression and a promising candidate for biomarker development and therapeutic targeting.
Harinivas Manthira Moorthi, D. V
· Biomedicine & pharmacotherap... · 0 citations